ReviewWorld journal of microbiology & biotechnology2026
Actinomycetes in the spotlight: biodiversity and their role in bioremediation.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Heavy metal tolerance in rare actinobacteria from Moroccan mining sites: first report of copper, zinc, and cobalt tolerance and zinc-associated antibacterial activity in Lentzea sp.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026Article
- Predictive functional profiling of 16S rRNA genes amplicons reveals bioremediation and sulfur metabolism capacity in thermophilic hot spring bacteriomes.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Actinomycetes represent a taxonomically and functionally diverse group of filamentous bacteria that are increasingly recognized for their role in environmental cleanup. Beyond their well-established capacity to produce antibiotics and other bioactive compounds, these microorganisms have shown remarkable potential in the degradation and transformation of a broad spectrum of pollutants, including petroleum hydrocarbons (e.g., crude oil, diesel), synthetic dyes (e.g., azo dyes), heavy metals (e.g., cadmium, lead), and pesticides (e.g., organochlorines). In recent years, significant progress has been made in uncovering novel actinomycete strains isolated from extreme and underexplored environments such as saline habitats, contaminated industrial sites, and marine sediments. These strains have demonstrated enhanced enzymatic activity and metabolic versatility in pollutant breakdown. Advances in molecular biology and omics-based techniques have further expanded our understanding of their biodegradative pathways and stress adaptation mechanisms. Nevertheless, several obstacles hinder their practical application, including inconsistent performance under field conditions, poor survival in competitive environments, and limited insight into their genetic regulation under contamination stress. This review not only summarizes current achievements (mainly from the last decade) but also highlights the urgent need for innovative strategies such as microbial consortia, metabolic engineering, and advanced formulation techniques to bridge the gap between laboratory findings and field-scale applications. Actinomycetes, therefore, stand as an untapped yet promising solution in the quest for efficient and eco-friendly bioremediation tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.